icon-folder.gif   Conference Reports for NATAP  
 
  The International Liver Congress™
EASL - European Association for the
Study of the Liver
2019 April 10-14
Vienna Austria
Back grey_arrow_rt.gif
 
 
 
Efficacy and Safety of glecaprevir/pibrentasvir for the Pangenotypic Treatment of Chronic Hepatitis C in former intravenous drug users: Subanalysis from a Spanish Real-World Cohort (Hepa-C)
 
 
  Reported by Jules Levin
EASL 2019 April 10-14 Vienna

0422191

0422192

0422193

0422194

0422195